Current studentsExisting staffContact us
 

Family History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden

Simple item page
dc.contributor.authorLin, E.
dc.contributor.authorGarmo, H.
dc.contributor.authorBeckmann, K.
dc.contributor.authorBratt, O.
dc.contributor.authorStattin, P.
dc.contributor.authorGedeborg, R.
dc.date.issued2025
dc.description.abstract<h4>Background</h4>A family history (FH) of prostate cancer increases the risk of prostate cancer, but its association with prostate cancer mortality remains unclear.<h4>Methods</h4>FH was defined as having a first-degree relative who was diagnosed before age 60 or died from prostate cancer. We used Cox regression to estimate associations between FH and prostate cancer characteristics at diagnosis, radical treatment, and prostate cancer death in men born after 1932 and diagnosed with prostate cancer between 1998 and 2020 in Sweden.<h4>Results</h4>Among 125,272 men with prostate cancer, 13,193 had an FH of early onset or lethal prostate cancer. At diagnosis, men with FH had 1.4 years lower median age, 0.87 ng/mL lower serum PSA, lower proportion of Gleason score 8 to 10 cancer (14.8% vs. 17.6%), lower odds for metastatic disease [OR, 0.79; 95% confidence interval (CI), 0.73-0.86], and higher odds for radical treatment (OR, 1.25; 95% CI, 1.18-1.32). With a median follow-up of 6.9 years and 12,773 prostate cancer deaths, mortality was lower (crude HR, 0.77; 95% CI, 0.73-0.82) in men with FH. Adjustment for prostate cancer characteristics attenuated this association (adjusted HR, 0.94; 95% CI, 0.88-1.00).<h4>Conclusions</h4>Men with prostate cancer and an FH of early onset or lethal prostate cancer had more favorable cancer characteristics, a higher likelihood of radical treatment, and similar prostate cancer mortality compared with men without an FH.<h4>Impact</h4>In men with prostate cancer, the risk of prostate cancer death seems unaffected by an FH of early onset or lethal prostate cancer after controlling for clinical characteristics. More research is needed on the potential role of screening.
dc.identifier.citationCancer Epidemiology, Biomarkers and Prevention, online, 2025; 34(9):1585-1592
dc.identifier.doi10.1158/1055-9965.EPI-25-0198
dc.identifier.issn1055-9965
dc.identifier.issn1538-7755
dc.identifier.orcidBeckmann, K. [0000-0002-9798-1479]
dc.identifier.urihttps://hdl.handle.net/11541.2/43778
dc.language.isoen
dc.publisherAMER ASSOC CANCER RESEARCH
dc.rightsCopyright 2025 The author(s). This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license.
dc.source.urihttps://doi.org/10.1158/1055-9965.EPI-25-0198
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectRisk Factors
dc.subjectAge of Onset
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectSweden
dc.subjectMale
dc.titleFamily History of Early Onset or Lethal Prostate Cancer and the Risk of Prostate Cancer Death in Sweden
dc.typeJournal article
pubs.publication-statusPublished
ror.mmsid9917047265201831

Files

Collections